Bristol-Myers Squibb is testing MORAb-202 in a Phase 2 trial to challenge traditional chemotherapy for platinum-resistant ...

Bristol Myers Squibb Co. stock grades by Barron's. View BMY fundamental and sentiment analysis powered by MarketGrader.

SoundHound AI provides a voice AI platform where its customers can create conversational AI assistants and voice-based AI ...

Looking into the current session, Bristol-Myers Squibb Inc. BMY shares are trading at $47.05, after a 1.22% drop. Over the ...

Bristol-Myers Squibb announced promising progress on its Phase 2 Alzheimer’s clinical trial of BMS-986446, an experimental ...

Revenues for the Legacy Portfolio plunged 20% in the first quarter to $5.64 billion due to the continued generic impact on ...

Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every ...

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity ...

The healthcare sector, represented by the Health Care Select Sector SPDR Fund (NYSEARCA:XLV), underperformed the broader market significantly in Q2 2025. With a 12.12% weighting in the S&P 500, ...

With AstraZeneca reported to be looking into moving its listing across the Atlantic, should investors buy the stock ahead of ...

In regular trading, the blue-chip Dow advanced 400 points, while the S&P 500 slipped 0.1%. The Nasdaq Composite lost 0.8% as ...